Summary
Colgate-Palmolive Co. reported net sales of $3,928 million for the third quarter of 2019, a 2.0% increase year-over-year, driven by volume growth and net selling price increases, partially offset by unfavorable foreign exchange. Organic sales, excluding these impacts, grew by 4.5%. For the nine-month period, net sales slightly decreased by 0.5% to $11,678 million, with organic sales growing 3.5%. The company successfully completed the acquisition of Laboratoires Filorga Cosmétiques (Filorga) for approximately $1.7 billion, bolstering its premium skin health portfolio. Profitability showed mixed results. While gross profit increased slightly for the quarter, operating profit saw a modest decrease due to increased selling, general, and administrative expenses, particularly higher advertising investment. Net income attributable to Colgate-Palmolive Company rose to $578 million from $523 million in the prior year quarter, with diluted EPS increasing to $0.67 from $0.60. The company continues to manage costs through its Global Growth and Efficiency Program, which is expected to achieve significant annual savings upon completion.
Financial Highlights
50 data points| Revenue | $3.93B |
| Cost of Revenue | $1.61B |
| Gross Profit | $2.32B |
| SG&A Expenses | $1.43B |
| Operating Income | $856.00M |
| Net Income | $578.00M |
| EPS (Basic) | $0.67 |
| EPS (Diluted) | $0.67 |
| Shares Outstanding (Basic) | 858.70M |
| Shares Outstanding (Diluted) | 861.20M |
Key Highlights
- 1Net sales increased by 2.0% to $3,928 million for the third quarter of 2019, with organic sales up 4.5%.
- 2Acquired the premium skin health business, Laboratoires Filorga Cosmétiques (Filorga), for approximately $1.7 billion.
- 3Net income attributable to Colgate-Palmolive Company increased to $578 million ($0.67 diluted EPS) in Q3 2019, up from $523 million ($0.60 diluted EPS) in Q3 2018.
- 4The Global Growth and Efficiency Program is on track to achieve substantial annual savings, with an expanded estimated pretax charge range of $1,865-$1,875 million.
- 5Operating profit margin (non-GAAP) decreased by 50 basis points to 22.9% in Q3 2019, impacted by higher raw material costs and increased SG&A expenses.
- 6Hill's Pet Nutrition segment showed strong growth with Net sales up 8.5% and organic sales up 10.0% in Q3 2019.
- 7The company repurchased approximately $5.0 billion in shares during the nine months ended September 30, 2019.